Ovarian Cancer Stage IIIC

Oncology·MeSH: Ovarian Neoplasms

Prevalence

18.1 / 100K

Incidence

4.4 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Ovarian Cancer Stage IIIC?

There are 1 clinical trial targeting Ovarian Cancer Stage IIIC tracked by BioSniper.

What is the prevalence of Ovarian Cancer Stage IIIC?

The estimated prevalence of Ovarian Cancer Stage IIIC is approximately 18.1 per 100,000 population.

Deep-dive into Ovarian Cancer Stage IIIC

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Ovarian Cancer Stage IIIC — Drugs in Development & Clinical Trials | BioSniper